# Dose-Escalating Study of BG9924 in Combination With Methotrexate in Active Rheumatoid Arthritis

> **NCT00292422** · PHASE2 · COMPLETED · sponsor: **Biogen** · enrollment: 50 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** BG9924

## Key facts

- **NCT ID:** NCT00292422
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2007-05
- **Final completion:** 2007-05
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2007-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00292422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00292422, "Dose-Escalating Study of BG9924 in Combination With Methotrexate in Active Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00292422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*